ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
155.42
-10.56 (-6.36%)
At close: Aug 6, 2025, 4:00 PM
155.96
+0.54 (0.35%)
After-hours: Aug 6, 2025, 6:15 PM EDT
Altus Power Market Cap
ICLR has a market cap or net worth of $12.09 billion as of August 6, 2025. Its market cap has decreased by -55.66% in one year.
Market Cap
12.09B
Enterprise Value
15.28B
1-Year Change
-55.66%
Ranking
Category
Stock Price
$155.42
Market Cap Chart
Since October 30, 2002, ICLR's market cap has increased from $278.50M to $12.09B, an increase of 4,240.16%. That is a compound annual growth rate of 18.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 12.91B | -25.44% |
| Dec 31, 2024 | 17.31B | -25.61% |
| Dec 29, 2023 | 23.27B | 46.86% |
| Dec 30, 2022 | 15.85B | -36.65% |
| Dec 31, 2021 | 25.01B | 139.26% |
| Dec 31, 2020 | 10.46B | 12.48% |
| Dec 31, 2019 | 9.30B | 33.02% |
| Dec 31, 2018 | 6.99B | 14.26% |
| Dec 29, 2017 | 6.12B | 47.97% |
| Dec 30, 2016 | 4.13B | -11.51% |
| Dec 31, 2015 | 4.67B | 48.72% |
| Dec 31, 2014 | 3.14B | 28.87% |
| Dec 31, 2013 | 2.44B | 45.97% |
| Dec 31, 2012 | 1.67B | 61.95% |
| Dec 30, 2011 | 1.03B | -20.24% |
| Dec 31, 2010 | 1.29B | 1.63% |
| Dec 31, 2009 | 1.27B | 11.99% |
| Dec 31, 2008 | 1.14B | -35.63% |
| Dec 31, 2007 | 1.76B | 66.90% |
| Dec 29, 2006 | 1.06B | 84.85% |
| Dec 30, 2005 | 571.80M | 7.64% |
| Dec 31, 2004 | 531.20M | 2.89% |
| Dec 31, 2003 | 516.30M | 62.61% |
| Dec 31, 2002 | 317.50M | 14.00% |
| Oct 30, 2002 | 278.50M | - |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |